SMARCB1 (INI-1)-deficient sinonasal carcinoma is a rare entity within the subgroup of poorly differentiated sinonasal tract carcinomas. As there are only two papers describing the cytologic features of this entity, herein we describe the unique cytomorphologic features of a pulmonary metastasis of this tumor and include the differential diagnosis based on tumor location. The patient was a 53-year-old male who initially presented with sinus congestion and vision changes including left-eye proptosis and diplopia. The initial biopsy of the ethmoid-centered sinonasal mass was non-keratinizing squamous cell carcinoma based on strong immunoreactivity with p40 and absence of immunoreactivity for chromogranin, synaptophysin, p16, and EBER. However, the final diagnosis of the surgical resection was amended to SMARCB1 (INI-1)-deficient sinonasal carcinoma after additional immunohistochemical stains were performed. Post-primary resection, follow-up computed tomography imaging revealed significant interval progression of a solitary, initially indeterminate 1-cm lung nodule in the left upper lobe. Endobronchial ultrasound-guided fine-needle aspiration with concomitant core-needle biopsy was performed. Rapid on site evaluation of cytologic smears revealed a hypercellular specimen consisting of sheets of epithelioid cells with very scant to absent cytoplasm, ill-defined cell borders, enlarged fragile nuclei, and areas of nuclear molding. Mitotic figures were present. Other areas showed tumor cells with spindled to elongated nuclei and scant to ill-defined wispy cytoplasm. Both cytology cell block and core-needle biopsy histopathologic material showed the tumor cells to be negative for INI-1 nuclear staining as well as CK5/6, CAM5.2, p40, p63, CK7, AE1/3, and TTF-1. SMARCB1 (INI-1)-deficient sinonasal carcinoma can have a spectrum of morphologies and may mimic “small-round-blue-cell” and spindle-cell tumors on cytology preparations. Given the pulmonary location of the aspirate, familiarity with the cytomorphologic spectrum of SMARCB1 (INI-1)-deficient sinonasal carcinoma, inclusion of this entity within the differential diagnosis, and performance of immunohistochemistry will aid in arriving at the correct diagnosis.

1.
Agaimy
A
,
Koch
M
,
Lell
M
,
Semrau
S
,
Dudek
W
,
Wachter
DL
, et al
SMARCB1(INI1)-deficient sinonasal basaloid carcinoma: a novel member of the expanding family of SMARCB1-deficient neoplasms
.
Am J Surg Pathol
.
2014
Sep
;
38
(
9
):
1274
81
.
[PubMed]
0147-5185
2.
Bishop
JA
,
Antonescu
CR
,
Westra
WH
.
SMARCB1 (INI-1)-deficient carcinomas of the sinonasal tract
.
Am J Surg Pathol
.
2014
Sep
;
38
(
9
):
1282
9
.
[PubMed]
0147-5185
3.
Agaimy
A
,
Hartmann
A
,
Antonescu
CR
,
Chiosea
SI
,
El-Mofty
SK
,
Geddert
H
, et al
SMARCB1 (INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphologic and Clinicopathologic Spectrum of a Recently Described Entity
.
Am J Surg Pathol
.
2017
Apr
;
41
(
4
):
458
71
.
[PubMed]
0147-5185
4.
Allison
DB
,
Bishop
JA
,
Ali
SZ
.
Cytopathologic characteristics of SMARCB1 (INI-1) deficient sinonasal carcinoma: A potential diagnostic pitfall
.
Diagn Cytopathol
.
2016
Aug
;
44
(
8
):
700
3
.
[PubMed]
8755-1039
5.
Allard
FD
,
Bell
D
,
Stelow
EB
.
Cytopathologic features of SMARCB1 (INI-1)-deficient sinonasal carcinoma
.
Cancer Cytopathol
.
2018
Aug
;
126
(
8
):
567
74
.
[PubMed]
1934-662X
6.
Kakkar
A
,
Antony
VM
,
Pramanik
R
, et al
SMARCB1 (INI1)-deficient sinonasal carcinoma: a series of thirteen cases with assessment of histological patterns
.
Hum Pathol
.
2018
;
Epub ahead of print
.0046-8177
7.
Kohashi
K
,
Oda
Y
.
Oncogenic roles of SMARCB1/INI1 and its deficient tumors
.
Cancer Sci
.
2017
Apr
;
108
(
4
):
547
52
.
[PubMed]
1347-9032
8.
Kim
KH
,
Roberts
CW
.
Mechanisms by which SMARCB1 loss drives rhabdoid tumor growth
.
Cancer Genet
.
2014
Sep
;
207
(
9
):
365
72
.
[PubMed]
2210-7762
9.
Laco
J
,
Chmelařová
M
,
Vošmiková
H
,
Sieglová
K
,
Bubancová
I
,
Dundr
P
, et al
SMARCB1/INI1-deficient sinonasal carcinoma shows methylation of RASSF1 gene: A clinicopathological, immunohistochemical and molecular genetic study of a recently described entity
.
Pathol Res Pract
.
2017
Feb
;
213
(
2
):
133
42
.
[PubMed]
0344-0338
10.
Wasserman
JK
,
Dickson
BC
,
Perez-Ordonez
B
,
de Almeida
JR
,
Irish
JC
,
Weinreb
I
.
INI1 (SMARCB1)-deficient sinonasal carcinoma: a clinicopathologic report of 2 cases
.
Head Neck Pathol
.
2017
Jun
;
11
(
2
):
256
61
.
[PubMed]
1936-055X
11.
Zeng
M
,
Chen
C
,
Yang
S
, et al
SMARCB1 (INI1)-deficient sinonasal carcinoma: a newly described entity
.
Int J Clin Exp Pathol
.
2016
;
9
:
3454
8
.1936-2625
12.
Bell
D
,
Hanna
EY
,
Agaimy
A
,
Weissferdt
A
.
Reappraisal of sinonasal undifferentiated carcinoma: SMARCB1 (INI1)-deficient sinonasal carcinoma: a single-institution experience
.
Virchows Arch
.
2015
Dec
;
467
(
6
):
649
56
.
[PubMed]
0945-6317
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.